Lymphadenectomy in Urothelial Carcinoma in the Renal Pelvis and Ureter


Condition: Ureteral Neoplasms

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT02607709

Sponsor: Zealand University Hospital

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: All

Inclusion Criteria:

  1. Age above 18 years
  2. Locally advanced high grade urothelial carcinoma in the renal pelvis or upper 2/3 of the ureter (Clinical stage > T1)
  3. Patient with ECOG performance score of 2 and less.
  4. Able to give informed consent

Exclusion Criteria:

  1. Clinical suspicion of non-muscle invasive UUTUC
  2. Metastatic urothelial carcinoma for the renal pelvis or upper 2/3 of the ureter
  3. Inability to understand written consent forms or give consent

View trial on ClinicalTrials.gov


email news signup